Cems Articles & Analysis: Older
8 news found
Ultravist-300, -370 receives green light for indication extension for use in contrast-enhanced mammography (CEM) in a European Workshare Procedure CEM is emerging modality combining digital mammography with the administration of a contrast agent Strategically expands Bayer’s portfolio in breast imaging, including contrast agents and injectors Bayer ...
ByBayer AG
” The Helen Brett™ Scholarship was established by Robert Kolinek, CEM, CMP, and named for his grandmother who was a pioneer in the trade show industry. ...
“The 20 Under 30 Program supports IAEE’s philosophy toward the importance of education and professional development by offering one of the best learning experiences possible to young professionals,” said IAEE EVP & COO Cathy Breden, CMP, CAE, CEM. “The wealth of education offerings and networking events at Expo! ...
“With the impressive technology of the production plant in Bilbao the ROXALL group gains a great potential in order to further explore new methods of therapy for the most important allergens worldwide”, says ROXALLs director Dr. Cem Gegin. With its strong position in the allergy section and its expertise in ultramodern technologies developing and manufacturing allergy ...
” Panelists include: Larry Garrone, CHESP, director, Services Response/Environmental Services/Patient Transport and Linen, Beth Israel Deaconess Medical Center, Boston; James Paturas, LP, CEM, CBCP, FACCP, director, Emergency Preparedness, Center for Emergency Preparedness and Disaster Response, Yale New Haven Health Center, Conn.; and Wes Thiss, CHESP, administrative ...
"Cleveland is the perfect fit for this conference, as it is home to the Cleveland Clinic, one of the largest and most green hospital networks in the country," said Carrie Abernathy, CMP, CEM, Director of Education, Training & Events for Practice Greenhealth. ...
This is the first major upgrade to the TumorManagerTM and incorporates many user requested enhancements making it the most flexible, powerful and easy to use pre-clinical oncology study management program available today. Dr. Cem Girit, Founder and President, added “we greatly appreciate the ongoing feedback and innovative suggestions from our users and look forward to ...
Previous placements were made at Johnson & Johnson’s Ortho Biotech Oncology R&D unit, AstraZeneca’s MedImmune unit, Covidien Imaging, Bayer and the Simon Cancer Center at Indiana University. Dr. Cem Girit, Founder and President, added “as we see our imagining technology gaining acceptance for preclinical oncology applications we can now continue ...